Kolaja Carey OConnor - Insider Non-Derivative Transactions at Revance Therapeutics, Inc. (RVNC) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Feb 6, 2025, Kolaja Carey OConnor's relationship to Revance Therapeutics, Inc. (RVNC) is Director, and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RVNC insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Kolaja Carey OConnor - Insider Non-Derivative Transactions of RVNC Common Stock

Kolaja Carey OConnor - Insider Non-Derivative Transactions at RVNC

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Feb 7, 2025	Disposition -- (Common Stock)	15000	0	0
Feb 5, 2025	U -- (Common Stock)	16561	3.65	15000
May 2, 2024	Acquisition -- (Common Stock)	15000	0	31561
Jun 16, 2023	Sell -- (Common Stock)	2500	28.24	16561
Jun 16, 2023	M -- (Common Stock)	2500	18.12	19061
May 4, 2023	Acquisition -- (Common Stock)	3534	0	16561